Status:
UNKNOWN
Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels
Lead Sponsor:
Marmara University
Conditions:
Thyroid Cancer
Breast Cancer
Eligibility:
All Genders
18-65 years
Brief Summary
Hypothesis: Dexamethasone reduces postoperative emesis in thyroidectomy and mastectomy patients.
Detailed Description
This study has been done to further study the effectiveness of dexamethasone in the prevention of postoperative emesis after breast and thyroid surgery and at the same time, the mechanism of action wa...
Eligibility Criteria
Inclusion
- breast and thyroid cancer patients no neoadjuvant treated no NSAID or steroid usage heallthy volunteers, signed the informed consent
Exclusion
- ones who did not sign the consent form NSAID or steroid users
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01811199
Start Date
February 1 2011
End Date
May 1 2013
Last Update
March 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University School of Medicine
Istanbul, Turkey (Türkiye)